Clinical trial Recruiting at 3 sites Interventional Ages 50 to 80

Turning-focused versus strength exercise to reduce freezing of gait in Parkinson's disease

Official title: TURN-IT FOG: A Novel Intervention to Improve Turning in People With PD and Freezing of Gait

Run by Oregon Health and Science University · NCT06815302 · Data updated 2026-11-12

This study tests whether a turning-focused agility program or a strength-based exercise program helps people with Parkinson's who have freezing of gait reduce freezing episodes and improve everyday mobility.

More Parkinson Disease trials

Quick facts

Study typeInterventional
Ages50 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorOregon Health and Science University
Academic / other
Locations3 sites (Tempe, Arizona and 2 other locations)
StatusRecruiting
StartedJune 2, 2025
Main results expectedDecember 31, 2026
Study endsJune 30, 2027
Registry record updatedJuly 28, 2025
Trial IDNCT06815302 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 50–80 with idiopathic Parkinson's disease (Hoehn & Yahr II–IV) who report freezing of gait, have sufficient cognitive ability for testing, and can attend moderate-intensity exercise sessions three times weekly.

Probably not a fit

Patients with major musculoskeletal, structural neurological disease, severe cognitive impairment (MoCA ≤21), vestibular or other non‑Parkinsonian causes of gait problems, or medical contraindications to moderate exercise are unlikely to benefit from these interventions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with Parkinson's and freezing of gait are randomly assigned to one of two supervised rehabilitation programs—turning-focused agility training or strength-based exercise—delivered one-on-one three times per week for six weeks. Researchers collect lab-based measurements before and after the intervention and use wearable mobility sensors to record walking and balance during daily life. Outcomes include patient- and clinician-rated measures of freezing, sensor-derived mobility metrics, and functional mobility in daily activities. The goal is to determine whether either approach meaningfully reduces freezing and improves mobility enough to justify a larger clinical trial.

Why it matters

Potential benefit: If successful, the program could reduce freezing episodes and improve day-to-day walking and balance through targeted exercise.

How similar studies have gone: Previous smaller rehabilitation and cueing studies have shown mixed but generally promising results for targeted exercise to reduce freezing, and this trial builds on that modest prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosis of idiopathic PD from movement disorders neurologist with the United Kingdom Brain Bank criteria of bradykinesia with one or more of the following - rest tremor, rigidity, and balance problems not from visual, vestibular, cerebellar or proprioceptive conditions
* reporting FOG in the New Freezing of Gait questionnaire (N-FOGQ)
* Hoehn \& Yahr stages II-IV
* ages 50-80 years old
* cognitive ability sufficient to participate in testing procedures and exercise classes
* be willing and able to participate in exercise intervention 3x/week for 6 weeks

Exclusion Criteria:

* Major musculoskeletal or neurological disorders, structural brain disease, epilepsy, acute illness or health history, other than PD, significantly affecting gait and turning (i.e., musculoskeletal disorder, vestibular problem, head injury, stroke, cardiac disease)
* medical condition or medications that precludes moderate-intensity exercise
* Montreal Cognitive Assessment (MoCA) ≤21 or inability to follow directions
* excessive use of alcohol or recreational drugs
* recent change in medication
* inability to stand and walk for 2 minutes without an assistive device

Where it's running

  • Arizona State University
    Tempe, Arizona, United States
    Recruiting
  • Oregon Health and Science University
    Portland, Oregon, United States
    Recruiting
  • University of São Paulo, Bauru Campus
    Bauru, São Paulo, Brazil
    Recruiting

Study contacts

  • Principal investigator: Martina Mancini, PhD — Oregon Health and Science University
  • Study coordinator: Graham R Harker, MPH
  • Email: harkerg@ohsu.edu
  • Phone: (503) 418-2601

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.